NovaMed senseAheart Rapid Diagnostic Kit
SensAheart is a new, super-sensitive rapid immunoassay for the early diagnosis of acute myocardial infarction (AMI) in pre-hospital conditions.
- SensA Heart rapid immunoassay for the early diagnosis of acute myocardial infraction (AMI).
- high 80.4% sensitivity level (competitive products are only 63.8%)
- Rapid results
- Able to be easily administered by on-site personnel
SensAheart is a simple, easy-to-use rapid test that does not require any additional equipment and specially trained personnel to diagnose AMI at the earliest stage of the disease.
The uniqueness of the SensAheart is in the patent technology of using a combination of specific antibodies in a single test to detect one or both cardiac biomarkers (hFABP and Troponin I) simultaneously, in one drop of capillary blood, in the 30-th minute from onset of the disease.
A positive result, due to the additive and summarized reaction of specific antibodies to the presence of one or both biomarkers in the blood, is expressed by one color band, providing a YES / NO qualitative result within 15 minutes.